Navigation Links
Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
Date:10/4/2007

ANN ARBOR, Mich., Oct. 4 /PRNewswire/ -- Richard D. Dyer, PhD, has been appointed Executive Vice President of Product Development for Velcura Therapeutics, Inc., an early stage biotechnology company developing potentially breakthrough therapies to treat bone diseases.

"We are pleased to add an individual of such high scientific caliber to our management team. Dr. Dyer will oversee our programs to develop second- generation therapies for bone diseases; he also will lead our new initiatives in inflammatory diseases." said Michael W. Long, PhD, president and CEO of Velcura Therapeutics, Inc.

Previous to joining Velcura Therapeutics Dr. Dyer was Vice President of Scientific Affairs and Development at TCH Pharmaceuticals, Inc. Prior to TCH, Dr. Dyer held progressively responsible positions at Pfizer Global Research and Development in Ann Arbor, eventually becoming Director of Inflammation Molecular Sciences and Technology. During his tenure with Pfizer, Dr. Dyer also provided scientific leadership at the distinguished position of Research Fellow in both Biochemistry and Inflammation Pharmacology.

Dr. Dyer completed his bachelors and masters degrees at Purdue University where he was a National Institutes of Health (NIH) Predoctoral Trainee in Environmental Toxicology and Radiation Health. He went on to earn his doctorate degree from the University of Wisconsin where he was both a NIH and Ford Foundation Predoctoral Trainee in Endocrinology/Reproductive Physiology. He was a NIH Postdoctoral Trainee in Endocrinology and Hypertension at the Medical College of Ohio before joining the Pharmaceutical Products Division of Abbott Laboratories in Illinois, where he played a pivotal role in the discovery and development of the FDA approved asthma treatment, Zyflo.

Dr. Dyer is past president and long-standing board member of the Inflammation Research Association. He has served as committee member and assisted in organizing various scientific conference
'/>"/>

SOURCE Velcura Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Former Fiserv exec to enter Business Hall of Fame
2. UW scientist, former WiCell director found stem cell company
3. Kyron appoints former AMA chairman to board
4. Genzyme sues former Bone Care employees
5. Former astronaut a leader in Wisconsin Spaceport
6. New book from former CDC CEO walks readers through innovation
7. Are top performers born or made?
8. Former Thompson lawyer comments on Doyle stem cell executive order
9. Searle spirit lives on in Chicago as alumni celebrate at former home
10. Former NSF director to speak at UW-Madison
11. PDS hires new VP, buys former health club building
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Grenoble, France and Dallas, TX, USA (PRWEB) , ... ... ... manufacturer of innovative nano and microsystems, has appointed Francois Vieillard as Sales & ... & Marketing at executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015   Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... supply industries, today reported financial results for the second ... half of 2015, we remain on track to achieve ... and Chief Executive Officer of the Company. "Since our ...
(Date:7/30/2015)... ... 2015 , ... As part of its 2015 growth plan and as a follow up to ... business units, Whitehouse Laboratories is pleased to announce that it has begun construction on a ... Excellence and will be strictly dedicated to basic USP 51, USP 61, and USP 62 ...
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: ... committed to progressing its ground-breaking technology platforms to Phase ... ensure the Company delivers the best value for shareholders. ... , said the Company currently had an extensive program ... programs and academic partnerships and initiatives, and he was ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... a privately-held company focused on advancing women,s reproductive health, today ... A financing, bringing the total funding to $20 million. The ... the round include Kleiner Perkins Caufield and Byers, TPG Biotech ... the last year, we have executed an aggressive operating plan ...
... 2012   Reportlinker.com announces that a new market ... U.S. Tissue Engineering Markets ... The scope of this research service primarily ... the wound care and surgery space. Surgery ...
... Feb. 1, 2012 Sangamo BioSciences, Inc. (Nasdaq: ... fourth quarter and full year 2011 financial results on Wednesday, ... will be followed by a conference call at 5:00 p.m. ... and webcast. During the conference call, the company will review ...
Cached Biology Technology:Auxogyn Completes $20 Million In Series A Funding 2Auxogyn Completes $20 Million In Series A Funding 3U.S. Tissue Engineering Markets 2U.S. Tissue Engineering Markets 3Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast 2
(Date:7/31/2015)... , Kina, 31. juli 2015 Den 10. ... afholdt af BGI fra den 22. - 25. oktober i ... Konferencen fejrer sin 10-års fødselsdag i år. Siden starten ... indflydelsesrige årlige møder på ,omik,-feltet, og er en af ... ICG-10 fokuserer på nylige gennembrud og fremskridt ...
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... a new way of looking beneath the ocean surface ... shrinking. , A remote sensor system developed by Associate ... at MIT, Northeastern University and the Naval Research Laboratory, ... as well as small schools, over a 10,000-square-kilometer area ...
... of Pennsylvania, demonstrate that biodegradable nano-particles containing two ... breast tumors. The unique properties of the ... to deliver two distinct drugs, paclitaxel, the leading ... Taxol, and doxorubicin directly to tumors implanted in ...
... have found a way to keep a protein "watchdog" on ... - if they can keep it on a leash of ... team of scientists including Purdue University's Susan M. Mendrysa has ... has the ability to halt the progression of intestinal tumors ...
Cached Biology News:One fish, two fish: New MIT sensor improves fish counts 2Nano-particles effective in killing cancer with one-two punch of chemotherapeutics 2Loosen leash on cancer protein 'watchdog,' researchers say 2Loosen leash on cancer protein 'watchdog,' researchers say 3Loosen leash on cancer protein 'watchdog,' researchers say 4
IEX-1 S/L (H-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
VAP-1 (S-13)...
Biology Products: